miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs
Open Access
- 1 January 2020
- journal article
- Published by Fortune Journals in Archives of Clinical and Biomedical Research
- Vol. 4 (3), 221-238
- https://doi.org/10.26502/acbr.50170100
Abstract
Glioblastoma (GBM) is the most common malignant primary brain tumor in adults and prognosis is poor despite maximum therapeutic efforts. GBM is composed of heterogeneous cell populations, among which the glioma stem-like cells (GSCs) play an important role in tumor cell self-renewal and the ability to initiate and drive tumor growth and recurrence. The transcription factor SOX2 is enriched in GSCs where it controls the stem cell phenotype, invasion and maintenance of tumorigenicity. Therefore, understanding the molecular mechanisms governed by SOX2 in GSCs is crucial to developing targeted therapies against this resistant cell population. In this study, we identified and validated a miRNA profile regulated by SOX2 in GSCs. Among these miRNAs, miR-425-5p emerged as a significant robust candidate for further study. The expression of miR- 425-5p was significantly enriched in clinical GBM specimens compared with a human brain reference sample and showed a positive correlation with SOX2 expression. Using a combination of in silico analyses and molecular approaches, we show that SOX2 binds to the promoter of miR-425-5p. Loss of function studies show that repressing miR-425-5p expression in multiple GSCs inhibited neurosphere renewal and induced cell death. More importantly, miR-425-5p inhibition extended survival in an orthotopic GBM mouse model. Finally, combining several bioinformatics platforms with biological endpoints in multiple GSC lines, we identified FOXJ3 and RAB31 as high confidence miR-425-5p target genes. Our findings show that miR-425-5p is a GBM stem cell survival factor and that miR-425-5p inhibition function is a potential strategy for treating GBM.Keywords
This publication has 41 references indexed in Scilit:
- Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 ProteinOnline Journal of Public Health Informatics, 2011
- Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant GliomasPLOS ONE, 2011
- Foxj3 transcriptionally activates Mef2c and regulates adult skeletal muscle fiber type identityDevelopmental Biology, 2010
- SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of TumorigenicityThe International Journal of Cell Cloning, 2009
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008
- Regulation of Self-Renewal and Pluripotency by Sox2 in Human Embryonic Stem CellsThe International Journal of Cell Cloning, 2008
- Rab22B’s role in trans-Golgi network membrane dynamicsBiochemical and Biophysical Research Communications, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- An implantable guide-screw system for brain tumor studies in small animalsJournal of Neurosurgery, 2000